|
GUIDA
alla SALUTE NATURALE
|
Abell
F, Krams M, Ashburner J, Passingham R, Friston K, Frackowiak R, Happé
F, Frith C, Frith U, ‘The neuroanatomy of autism: a voxel-based whole
brain analysis of structural scans’, NeuroReport, June 1999,
Vol. 10, No. 8, 1647-1651 |
|
Adams
CR, Ziegler DK, Lin JT, ‘Mercury intoxication simulating amyotrophic
lateral sclerosis’, JAMA 1983; 250:642-643. |
|
Al-Balaghi
S, Möller E, Möller G, Abedi-Valugerdi M, ‘Mercury induces
polyclonal B cell activation, autoantibody production and renal immune
complex deposits in young (NZB x NZW) F1 hybrids’, Eur J Immunol,
July 1996, 26(7):1519-1526 |
|
Alberti
A, Pirrone P, Elia M, Waring RH, Romano C, ‘Sulphation deficit in
“low-functioning” autistic children: a pilot study’, Biol
Psychiatry 1999 Aug 1; 46(3):420-424 |
|
Altman
DG, Bland JM, ‘Absence of evidence is not evidence of absence’, Br
Med J, 1995;311:485 |
|
American
Academy of Pediatrics and US Public Health Service, July 8, 1999,
'Thimerosal, a Mercury-containing Preservative Used in Some Vaccines' |
|
American
Psychiatric Association: Diagnostic and Statistical Manual of Mental
Disorders, Fourth Edition, Washington D.C., 1994 |
|
Amin-Zaki
L, Majeed MA, Clarkson TW, Greenwood MR, ‘Methylmercury poisoning in
Iraqi children: clinical observations over two years’, British
Medical Journal 1978 March 1, 613-616 |
|
Amin-Zaki
L, Majeed MA, Elhassani SB, Clarkson TW, Greenwood MR, Doherty RA,
‘Prenatal Methylmercury Poisoning’, American Journal of the
Disabled Child, 1979 Feb 133:172-177 |
|
Amin-Zaki,
L, Elhassani S, Majeed MA, Clarkson TW, Doherty RA, Greenwood M,
‘Intra-uterine methylmercury poisoning in Iraq’, Pediatrics
1974 Nov 54:5587-595 |
|
Anuradha
B, Rajeswari M, Varalakshmi P, ‘Degree of peroxidative status in
neuronal tissues by different routes of inorganic mercury
administration’, Drug Chem Toxicol 1998 Feb;21(2):47-55 |
|
Applied
Toxicology,
1992 Apr;12(2):79-84 |
|
ARI
Newsletter,
review, 'Long term follow-up: early intervention effects lasting', 1993
7(1):1&6 |
|
Aronow
R, Fleischmann L ,‘Mercury Poisoning in Children’, Clinical
Pediatrics, 1976 Oct, Vol.15, No.10, 936-945 |
|
Arvidsson
T, Danielsson B, Forsberg P, Gillberg C, Johansson M, Kjellgren G, ‘
Autism in 3-6 year old children in a suburb in Göteborg, Sweden’, Autism,
November 1997, Vol. 1, No. 2, 163-173 |
|
Aschner
M, Aschner JL, ‘Mercury Neurotoxicity: Mechanisms of Blood-Brain
Barrier Transport’, Neuroscience & Behavioral Reviews,
1990, Vol. 14, 169-176 |
|
Aschner
M, Lorscheider FL, Cowan KS, Conklin DR, Vimy MJ, Lash LH,
‘Methallothionein induction in fetal rat brain and neonatal primary
astrocyte cultures by in utero’, Brain Res, Dec 5;
778(1):222-232 |
|
Ashour
H, Abdel-Rahman M, Khodair A., 1993 ‘The mechanism of methyl mercury
toxicity in isolated rat hepatocytes’, Toxicology Letters 1993
Jul;69(1):87-96 |
|
Atchison
WD and Hare MF, ‘Mechanisms of methylmercury-induced neurotoxicity’,
FASEB Journal 1994 Jun;8(9):622-629 |
|
Atchison
WD, Joshi U, Thornburg JE, ‘Irreversible Suppression of Calcium Entry
into Nerve Terminals by Methylmercury’, The Journal of Pharmacology
and Experimental Therapeutics, 1986, Vol. 238, No. 2, 618-624 |
|
Aukrust
P, et al, ‘Decreased levels of total and reduced glutathione in CD4+
lymphocytes in common variable immunodeficiency are associated with
activation of the tumor necrosis factor system: possible
immunopathogenic role of oxidative stress’, Blood, 1995,
86.4.1383-1391 |
|
Aukrust
P, et al, 'Persistent activation of the tumor necrosis factor system in
subgroup of patients with common variable immunodeficiency - possible
immunological and clinical consequences’, Blood, 1996,
97.2.674-681 |
|
Aylward
EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates KO, Barta
PE, Pearlson GD, 'MRI volumes of amygdala and hippocampus in
non-mentally retarded autistic adolescents and adults', Neurology
1999 Dec 10;53(9):2145-50 |
|
Bachevalier
J, 'Brief Report: Medial Temporal Lobe and Autism: A Putative Animal
Model in Primates', Journal of Autism and Developmental Disorders,
1996;26(2):217-220 |
|
Bachevalier
J, 'Medial Temporal Lobe Structures: a Review of Clinical and
Experimental Findings', Neuropsychologia, 1994;32:627-648 |
|
Bagenstose
LM, Salgame P, Monestier M, ‘Mercury-induced autoimmunity in the
absence of IL-4’, Clin Exp Immunol, Oct 1998, 114(1):9-12 |
|
Bagenstose
LM, Salgame P, Monestier M, ‘Murine mercury-induced autoimmunity: a
model of chemically related autoimmunity in humans’, Immunol Res,
1999, 20(1):67-78 |
|
Bailey
A, Phillips W, Rutter M, ‘Autism: Towards an Integration of Clinical,
Genetic, Neuro-psychological, and Neurobiological Perspectives’, J
Child Psychol Psychiatry 1996 Jan; 37(1): 89-126. |
|
Bailey
A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M,
Lantos, 'A clinicopathological study of autism', Brain 1998
May;121 ( Pt 5):889-905 |
|
Bakir
F, Damluji SF, Amin-Zaki L,
Murtadha M, Khalidi A, Al-Rawi NY, Tikrit S, Dhahir HI, Clarkson TW,
Smith JC, Doherty RA, ‘Methylmercury poisoning in Iraq’, Science,
July 1973, 181;230-241 |
|
Baranek
G, 'Autism During Infancy: A
Retrospective Video Analysis of Sensory-Motor and Social Behaviors and
9-12 Months of Age', Journal of Autism and Developmental Disorders,
1999, Vol. 29, No. 3, pp. 213-224 |
|
Baron-Cohen
S, Ring HA, Wheelwright S, Bullmore ET, Brammer MJ, Simmons A, Williams
SC, 'Social intelligence in the normal and autistic brain: an fMRI
study', Eur J Neuroscience 1999 Jun;11(6):1891-8 |
|
Baron-Cohen
S, Leslie A, Frith U, ‘Does the autistic child have a ‘theory of
mind’?’, Cognition, 1985, No. 21, pp. 37-46 |
|
Baron-Cohen
S, Allen J, Gillberg C, 'Can autism be detected at 18 months: the
needle, the haystack, and the CHAT', Br. J. Psychiatry,
1992;161:839-843 |
|
Baron-Cohen
S, Tager-Flusberg H, Cohen D, Understanding Other Minds: Perspectives
from Autism, Oxford: Oxford University Press, 1993 |
|
Barregard
L, Sallsten G, Conradi N, ‘Tissue levels of mercury determined in a
deceased worker after occupational exposure’, Int Arch Occup
Environ Health 1999 May;72(3):169-173 |
|
Bartolome
J, Whitmore WL, Seidler FJ, Slotkin TA 1984 ‘Exposure to methylmercury
in utero: effects on biochemical development of catecholamine
neurotransmitter systems’, Life Sciences 1984 Aug
6;35(6):657-670 |
|
Bauman
ML, Kemper TL, 'Neuroanatomical observations of the brain in autism', in
Bauman & Kemper, eds, The Neuroanatomy of Autism, The Johns
Hopkins University Press |
|
Bauman
ML and Kemper TL, Journal of Experimental Neurology, 1988 47:369 |
|
Bauman
M, Kemper TL, 'Histoanatomic observations of the brain in early
infantile autism', Neurology, 1985;35:866-874 |
|
Bernabei
P, Camaioni L, Levi G, ‘An evaluation of early development in children
with autism and pervasive developmental disorders from home movies:
preliminary findings’, Autism, September 1999, Vol. 2, No. 3,
243-258 |
|
Bettleheim
B, 'A letter from Bruno Bettleheim', Autism Research Review
International, 1989, Vol
3, No. 3, p. 6 |
|
Bidet
B, Leboyer M, Descours B, Bouvard MP, Benveniste J, ‘Allergic
sensitization in infantile autism’ (letter), Journal of Autism and
Developmental Disorders, June 1993, Vol. 23, No. 2, pp. 419-420 |
|
Binstock
T, 'Fragile X and the amygdala: cognitive, interpersonal, emotional, and
neuroendocrine considerations', Dev Brain Dysfunction 1995
8:199-217 |
|
Bonnet
JJ, Benmansour S, Amejdki-Chab N, Costentin J, ‘Effect of CH3HgCl and
several transition metals on the dopamine neuronal carrier; peculiar
behaviour of Zn2+’, Eur J Pharmacol 1994 Jan 1;266(1)87-97 |
|
Bouilleret
V, Boyet S, Marescaux C, Nehlig A, ‘Mappingof the progressive
metabolic changes occurring during the development of hippocampal
sclerosis in a model of mesial temporal lobe epilepsy’, Brain
Research, 2000, 952:255-262 |
|
Brenner
RP and Snyder RD, ‘Late EEG finding and clinical status after organic
mercury poisoning’, Archives of Neurology 1980 May;
37(5):282-284 |
|
Bristol
M, Cohen D, Costello E, Denckla M, Eckberg T, Kallen R, Kraemer H, Lord
C, Maurer R, McIlvane W, Minshew N, Sigman M, Spence M, 'State of the
Science in Autism: Report to the National Institutes of Health' , Journal
of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, pp.
121-157 |
|
Bryson
SE, ‘Brief Report: Epidemiology of Autism’, Journal of Autism and
Developmental Disorders, 1996, Vol. 26, No. 2, 165-167 |
|
Bryson
SE, Smith IM, Eastwood D, 'Obstetrical suboptimality in autistic
children', J Am Acad Child Adolesc Psychi, 1988;27(4)418-22 |
|
Bulleit
RF, Cui H, ‘Methylmercury antagonizes the survival-promoting activity
of insulin-like growth factor on developing cerebellar granule
neurons’, Toxicol Appl Pharmacol 1998 Dec;153(2):161-168. |
|
Bulleit
RF, Cui H, ‘Methylmercury antagonizes the survival-promoting activity
of insulin-like growth factor on developing cerebellar granule
neurons’, Toxicol Appl Pharmacol 1998 Dec;153(2):161-168 |
|
Cagiano
R, De Salvia MA, Renna G, Tortella E, Braghiroli D, Parenti C, Zanolie
P, Baraldi M, Annau Z, Cuomo V, ‘Evidence that exposure to methyl
mercury during gestation induces behavioral and neurochemical changes in
offspring of rats’, Neurotoxicol Teratol 1990 Jan-Feb;12(1):23-28 |
|
Camerino
, Cassitto M, 'Behavior of Some Psychological Parameters of a Population
of a Hg Extraction Plant', Journal of Clinical Toxicology, 1981,
Vol. 18 (11), pp. 1299-1309 |
|
Capps
L, Kehres J, Sigman M, 'Conversational abilities among children with
autism and children with developmental delays', Autism, 1998 Dec;2(4):325-44 |
|
Carlsson
ML, ‘Hypothesis: is infantile autism a hypoglutamatergic disorder?
Relevance of glutamate - serotonin interactions for pharmacotherapy’, Journal
of Neural Transmitters 1998 105(4-5):525-535 |
|
Carlsson
ML, Martin P, Nilsson M, Sorensen SM, Carlsson A, Waters S, Waters N,
‘The 5-HT2A receptor antagonis M100907 is more effective in
counteracting NMDA antagonist- than dopamine agonist-induced
hyperactivity in mice’, J Neural Transm 1999; 106(2):123-129 |
|
Carpenter
PK, Morris D, ‘Association of acrocyanosis with Asperger’s
syndrome’, Journal of Mental Deficiency Research, 1990, 34, pp.
97-90 |
|
Carroll
L, Alice in Wonderland, W.W. Norton & Company, 1992, 1971 |
|
CDC,
‘Recommendations Regarding the Use of Vaccines That Contain Thimerosal
as a Preservative’, MMWR November 5, 1999 / 48(43); 996-998 |
|
CDC,
‘Thimerosal in vaccines: a joint statement of the Amercian Academy of
Pediatrics and the Public Health Service’, MMWR Morb Mortal Wkly
Rep 1999 July 9; 48(26):563-565 |
|
CDC,
'Record Immunization Rate, 80% of Kids Getting Vaccinated', Associated
Press, September 23, 1999 |
|
Cesaroni
L, Garber M, 'Exploring the experience of autism through firsthand
accounts', Journal of Autism and Developmental Disorders, 1991
Sep;21(3):303-13 |
|
Chapman
AG, Elwes RD, Millan MH, Polkey CE, Meldrum BS, 'Role of Glutamate and
Aspartate in Epileptogenesis; Contribution of Microdialysis Studies in
Animal and Man', Epilepsy Res Suppl, 1996, Vol. 12, pp. 239-246 |
|
Cheek
DB, 'Acrodynia', in Brennemann's Practice of Pediatrics, Chapter
17D, from Pink Disease website, www.users.bigpond.com/difarnsworth/pcheek42.htm |
|
Chodorowski
Z, Sein Anand J, Nowicki A, Galant K, ‘Subcutaneous self-injection and
oral self-administration of metallic mercury - case report’, Przegl
Lek 1997;54(10):759-762 |
|
Chu
CC, Huang CC, Ryu SJ, Wu TN, ‘Chronic inorganic mercury induced
peripheral neuropathy’, Acta Neurology Scandanavia 1998 Dec;98(6):461-465 |
|
Chugani
DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani HT,
‘Developmental Changes in Brain Serotonin Synthesis Capacity in
Autistic and Nonautistic Children’, Ann Neurol 1999; 45: |
|
Church
C, Coplan J, 'The High Functioning Autistic Experience: Birth to Preteen
Years', Journal of Pediatric Health Care, 1995, Vol. 9, pp.22-29 |
|
Clarke
D, Baxter M, Perry D, Prasher V, 'The diagnosis of affective and
psychotic disorders in adults with autism: seven case reports', Autism,
1999 Jun;3(2):149-164 |
|
Clarkson
TW, ‘Mercury: Major Issues in Environmental Health’, Environmental
Health Perspectives vol. 100, pp. 31-38, 1992 |
|
Clarkson,
T. 1997 ‘The Toxicology of Mercury’, Critical Reviews in Clinical
Laboratory Sciences, 34(3): 369-403 (1997) |
|
Clarkson,
TW, ‘Mercury - an element of mystery’, The New England Journal of
Medicine 1990 Oct 18 |
|
Clarkson,T.W,
1993, 'Molecular and ionic mimicry of toxic metals', Annu. Rev.
Pharmacol. Toxicol. 32:545-571 |
|
Cloarec
S, Deschenes G, Sagnier M, Rolland JC, Nivet H, ‘Arterial hypertension
due to mercury poisoning: diagnostic value of captopril’, Arch
Pediatr 1995 Jan;2(1):43-46 |
|
Close
AH, Guo TL, Shenker BJ, ‘Activated human T lymphocytes exhibit reduced
susceptibility to methylmercury chloride-induced apoptosis’, Toxicol
Sci 1999 May;49(1):68-77 |
|
Coccini
T, Randine G, Candura SM, Nappi RE, Prockop LD, Manzo L, ‘Low-Level
Exposure to Methylmercury Modifies Muscarinic Cholinergic Receptor
Binding Characteristics inRat Brain and Lymphocytes: Physiologic
Implications and New Opportunities in Biologic Monitoring’, Environ
Health Perspect, 2000 Jan;108(1):29-33 |
|
Coleman
M, ‘Nutritional treatments currently under investigation in autism’,
Clinical Nutrition, Sept/Oct 1989, Vol. 8, No. 5, pp. 210-212 |
|
Comi
AM, Zimmerman A et al, 'Familial clustering of autoimmune disorders and
evaluation of medical risk factors in autism', Journal of Child
Neurology, 1999, Vol. 14, pp. 388-394 |
|
Connolly
AM, et al, ‘Serum autoantibodies to brain in Landau-Kleffner variant,
autism, and other neurologic disorders’, Journal of Pediatrics,
May 1999, Vol. 134, No. 5, pp. 607-613 |
|
Cook
EH, ‘Autism: review of neurochemical investigation’, Synapse,
1990, 6:292-308 |
|
Courchesne
E, et al,‘More evidence links autism, cerebellar defects’, reviewed
in Autism Research Review International, 1994, Vol. 8, No. 2, pp.
1&7 |
|
Courchesna
E, Press GA, Young-Courchesne R, 'Parietal lobe abnormalities detected
with MR in patients with infantile autism', AJR Am J Roentgenol
1993 Feb;160(2):387-93 |
|
Courchesne
E, 'Brainstem, cerebellar and limbic neuroanatomical abnormalities in
autism', Current Opin Neurobiol 1997 Apr;7(2):269-78 |
|
Courchesne
E, Saitoh O, Townsend J, Yeung-Courchesne R, Lincoln AJ, Schreibman L,
Haas RH, Press GA, 'Cerebellar Abnormalities in Autism: New Evidence and
A Re-Analysis of Old Evidence', pp. 211-214 |
|
Courchesne
E, Yeung-Courchesne R, Elmasian R, Grillon C, 'Pathophysiologic findings
in non-retarded autism and receptive developmental language disorder', Journal
of Autism and Developmental Disorders, 1989; 19:1-17 |
|
Courchesne
E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL,
‘Hypoplasia of cerebellar vermal lobules VI and VII in autism’, New
England Journal of Medicine 1988 318:1349-1354 |
|
Courchesne
E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL,
‘Hypoplasia of cerebellar vermal lobules VI and VII in autism’, New
England Journal of Medicine, May 26, 1998; pp. 1349-1354 |
|
Courchesne
E, reported in The New York Times, 'Science Times' section, Dec
28, 1999, by Blakeslee S |
|
Cox
NH, Forsyth A, ‘Thiomersal allergy and vaccination reactions’, Contact
Dermatitis 1988:18:229-233 |
|
Creel
DJ, Crandall AS, Pingree C, Ritvo ER, 'Abnormal electroretinograms in
autism', Clinical Vision Science 1989 4(1):85-88 |
|
Cuomo
V, Ambrosi L, Annau Z, Cagiano R, Brunello N, Racagni G 1984,
‘Behavioral and neurochemical changes in offspring of rats exposed to
methyl mercury during gestation’, Neurobehavior Toxicology Teratol
1984 May-June;6(3):249-254 |
|
D’Eufemia
P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E,
Giardini O, ‘Abnormal intestinal permeability in children with
autism’, Acta Pædiatr 1996:85:1076-1079 |
|
D’Eufemia
P, Finocchiaro R, Celli M, Viozzi L, Monteleone D, Giardini O, ‘Low
serum tryptophan to large neutral amino acids ratio in idiopathic
infantile autism’, Biomed. &
Pharmacother.,
1995, Vol. 49, pp. 288-292 |
|
Dales
LD, ‘The Neurotoxicity of Alkyl Mercury Compounds’, American journal
of Medicine, August 1972, Vol. 53, 219-232 |
|
Dally
A, 'The Rise and Fall of Pink Disease', Wellcome Institute for the
History of Medicine, 1997, available at www.users.bigpond.com/difarnsworth |
|
Dathan
JG, 'Pink Disease-Ten Years After (The Epilogue), British Medical
Journal, 1965, Vol 1, pp. 1181-1182 |
|
Dave
V, Mullaney KJ, Goderie S, Kimelberg HK, Aschner M, ‘Astrocytes as
mediators of methylmercury neurotoxicity: effects on D-aspartate and
serotonin uptake’, Dev Neurosci 1994;16(3-4):222-231 |
|
Davis
LE, Kornfeld M, Mooney HS, Fiedler KJ, Haaland KY, Orrison WW,
Cernichiari E, Clarkson TW, ‘Methylmercury poisoning: long term
clinical, radiological, toxicological, and pathological studies of an
affected family’, Annals of Neurology 1994 35:6 680-688 |
|
Dawson
G, ‘Brief Report: Neuropsychology of Autism: A Report on the State of
the Science’, Journal of Autism and Developmental Disorders,
1996, Vol. 26, No. 2, 179-184 |
|
Deb
S and Thompson B, ‘Neuroimaging in autism’, British Journal of
Psychiatry 1998 Oct 173:299-302 |
|
DelGiuidce-Asch
G, Hollander E, ‘Altered immune function in autism’, CNS
Spectrums: International Journal of Neuropsychiatric Medicine, 1997,
2:61-68 |
|
DeLong
GR, ‘Autism: new data suggest a new hypothesis’, Neurology,
March 1999, Vol. 52, No. 5, pp. 911-916 |
|
Deutsch
S, Campbell M, Sachar E, Green W, David R, ‘Plasma growth hormone
response to oral L-dopa in infantile autism’, Journal of Autism and
Developmental Disorders, June 1985, Vol. 15, No. 2, pp. 205-212 |
|
Deyab
P, Gochfeldbc M, Reuhlabca K, 'Developmental Methylmercury
Administration Alters Cerebellar PSA-NCAM expression and Golgi
sialyltransferase Activity', 1999 |
|
Diner
Barry, M.D., Brenner Barry, M.D.,Toxicity, Mercury, 1998 |
|
Edelson
MG, Edelson SM, Jung S, ‘Assessing the Intelligence of Individuals
with Autism: A Cross-Cultural Replication of the Usefulness of the
TONI’, Focus on Autism and Other Developmental Disabilities,
Winter 1998, Vol. 13, No. 4, 221-227 |
|
Edelson
MG, Schubert DT, Edelson SM, ‘Factors Predicting Intelligence Scores
on the TONI in Individuals with Autism’, Focus on Autism and Other
Developmental Disabilities, Spring 1998, Vol. 13, No. 1, 17-26 |
|
Edelson
SB, Cantor DS, ‘Autism: xenobiotic influences’, Toxicol Ind
Health, 1998 Jul-Aug;14(4):553-563 |
|
Egan,
William M. 1999 ‘Thimerosal in Vaccines’, presentation to the FDA,
September 14, 1999 |
|
Eisenmayer
R et al, 'Delayed language onset as a predictor of clinical symptoms in
pervasive developmental disorders', Journal of Autism and
Developmental Disorders, 1998 Dec 28(6):527-33 |
|
El-Fawal
HA, Waterman SJ, De Feo A, Shamy MY, ‘Neuroimmunotoxicology: Humoral
Assessment of Neurotoxicity and Autoimmune Mechanisms’, Environ
Health Perspect 1999 Oct;107(Suppl 5):767-775 |
|
El-Fawal
HA, Waterman SJ, DeFeo A, Shamy MY, ‘Neuroimmunotoxicology: Humoral
Assessment of Neurotoxicity and Autoimmune Mechanisms’, Environ
Health Perspect 1999 Oct;107(Suppl5):767-775 |
|
Elferink
JG Thimerosal: a versatile sulfhydryl reagent,calcium mobilizer, and
cell function-modulating agent.Gen Pharmacol 1999 Jul;33(1):1-6 |
|
Environmental
Protection Agency (EPA), lead authors - Hassett-Sipple B, Swartout J,
Schoeny R, 'Vol. V - Health Effects of Mercury and Mercury Compounds', Mercury
Study Report to Congress, December 1997 |
|
Ernst
M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM, 'Low medial
prefrontal dopaminergic activity in autistic children', Lancet
1997 Aug 30;350(9078):638 |
|
Eto
K, Takizawa Y, Akagi H, Haraguchi K, Asano S, Takahata N, Tokunaga H,
‘Differential diagnosis between organic and inorganic mercury
poisoning in human cases - the pathologic point of view’, Toxicol
Pathol 1999 Nov-Dec;27(6):664-671 |
|
Fagala
GE,Wigg CL, ‘Psychiatric Manifestions of Mercury Poisoning’, J.
Am. Acad. Child. Adolesc. Psychiatry, March 1992,
31(2):306-311. |
|
Fagan
DG, Pritchard JS, Clarkson TW, Greenwood MR, ‘Organ mercury levels in
infants with omphaloceles treated with organic mercurial antiseptic’, Archives
of Disease in Childhood, 1977 52:962-964 |
|
Farnsworth
D, ‘Pink Disease Survey Results’, Pink Disease Support Group Site,
1997 www.users.bigpond.com/difarnsworth |
|
Faro
LR, Duran R, do Nascimento JL, Alfonso M, Picanco-Diniz CW, ‘Effects
of methyl mercury on the in vivo release of dopamine and its acidic
metabolites DOPAC and HVA from Striatum of rats’, Ecotoxicol
Environ Saf 1997 Nov;38(2):95-98 |
|
Faro
LRF, Nascimento JLM do, Alfonso M, Duran R, ‘Acute Administration of
Methylmercury Changes In Vivo Dopamine Release from Rat
Striatum’, Bulletin of Environmental Contamination Toxicology,
1998 60:632-638 |
|
FDA,
HHS, ‘Mercury Containing Drug Products for Topical Antimicrobial
Over-the-Counter Human Use; Establishment of a Monograph’, Federal
Register, January 5 1982, Vol. 47, No. 2, 436-442 |
|
FDA,
'Mercury Compounds in Drugs and Food', 98N-1109, November 16, 1999 |
|
Feldman
R, 'Neurological Manifestations of Mercury Intoxication', Journal of
Occupational Neurology, 1982, Vol. 66, pp. 201-209 |
|
Filipek
P, Accardo P, Baranek G, Cook E, Dawson G, Gordon B, Gravel J, Johnson
C, Kallen R, Levy S, Minshew N, Prizant B, Rapin I, Rogers S, Stone W,
Teplin S, Tuchman R, Volkmar F, 'The Screening and Diagnosis of Autistic
Spectrum Disorders', Journal of Autism and Developmental Disorders,
1999, Vol. 29, No. 6, pp. 439-484 |
|
Filipek
PA, Accardo PJ, Baranek GT, Cook Jr. EH, Dawson G, Gordon B, Gravel JS,
Johnson CP, Kallen RJ, Levy SE, Minshew NJ, Prizant BM, Rapin I, Rogers
SJ, Stone WL, Teplin S, Tuchman RF, Volkmar FR, ‘The Screening and
Diagnosis ot Autistic Spectrum Disorders’, Journal of Autism and
Developmental Disorders, 1999, Vol. 29, No. 6, 439-484 |
|
Finegan
J, Quarrington B, 'Pre-, peri-, and neonatal factors and infantile
autism', J Child Psychol Psychi, 1979; 20.119-128 |
|
Florentine
MJ and Sanfilippo II DJ, ‘Grand Rounds: Elemental mercury
poisoning’, Clinical Pharmacy 1991 Mar 10:213-221 |
|
Fombonne
E, Rogé B, Claverie J, Courty S, Frémolle J, ‘Microcephaly and
Macrocephaly in Autism’ Journal of Autism and Developmental
Disorders, 1999, Vol. 29, No. 2, 113-119 |
|
Food
and Drug Administration, 1997 ‘Status of Certain Additional
Over-the-Counter Drug Category II and III Active Ingredients’, Docket
Nos. 75N-183F, 75N-183D, and 80N-0280, October 19,1998 |
|
Fournier
L, Thomas, G, Garnier, R, Buisine, A, Houze, P, Pradier, F, and Dally, S
1988, ‘2,3-Dimercaptosuccinic Acid Treatment of Heavy Metal Poisoninig
in Humans’, Medical Toxicology 3: 499-505 (1988) |
|
Frackelton
JP, Christensen RL, ‘Mercury Poisoning and Its Potential Impact on
Hormone Regulation and Aging: Preliminary Clinical Observations Using a
New Therapeutic Approach’, Journal of Advancement in Medicine
1998 Spring 11(1):9-25 |
|
Fredriksson
A, Dencker L, Archer T, Danielsson BGR, ''Prenatal coexposure to
metallic mercury vapour and methylmercury produce interactive
behavioural changes in adult rats', Neurotoxicol Teratol 1996
19(2):129-134 |
|
Fuchs
J, Packer L, Zimmer G, Lipoic Acid in Health and Disease, Marcel
Dekker, Inc., 1997 |
|
Fuchs
J, Schöfer H, ‘Redox Modulation of Signal Transduction and Gene
Expression in HIV Infection: The Role of the Antioxidant Lipoate’, Lipoic
Acid in Health and Disease, Fuchs, Packer, & Zimmer (eds),
Marcel Dekker, Inc., 1997, 435-454 |
|
Fudenberg
HH, ‘Dialysable Lymphocyte Extract (DLyE) in Infantile Onset Autism: A
Pilot Study’, Biotherapy (1996) 9:143-147 |
|
Fukino
H, Hirai M, Hsueh YM, Yamane Y,‘Effect of zinc pretreatment on
mercuric chloride-induced lipid peroxidation in the rat kidney’, Toxicol
Appl Pharmacol 1984 May;73(3):395-401 |
|
Gaffney
GR, Kuperman S, Tsai LY, Minchin S, ‘Morphological evidence for
brainstem involvement in infantile autism’, Biological Psychiatry,
September 1988, 24:578-586 |
|
Gedye
A, ‘Anatomy of self-injurious, stereotypic, and aggressive movements:
evidence for involuntary explanation’, Journal of Clinical
Psychology, November 1992, Vol. 48, No. 6, pp. 766-778 |
|
Gilbert
SG, Grant-Webster KS, ‘Neurobehavioral effects of developmental
methymercury exposure’, Environmental Health Perspectives, 1995
Sept; 103 Suppl 6:135-142 |
|
Gillberg
C, Coleman M, The Biology of the Autistic Syndromes - 2nd Edition,
Mac Keith Press, 1992 |
|
Gillberg
C, Dev Med Child Neurol 37, 23-45 (1995) |
|
Gillberg
C, Gillberg IC, 'Infantile Autism: a total population study of reduced
optimality in the pre-, peri- and neonatal period', Journal of Autism
and Developmental Disorders, 1983, Vol 13, No. 2, pp. 153-166 |
|
Gillberg
C, Svennerholm L, ‘CSF monoamines in autistic syndromes and other
pervasive dev. disorders of early childhood’, British Jour. of
Psychiatry, 1987, No. 151, pp. 89-94 |
|
Gillberg
C, Wing L, ‘Autism: not an extremely rare disorder’, Acta
Psychiatr Scand 1999 Jun;99(6)399-406 |
|
Goldberg
M, Mena I, Miller B, ‘Frontal and temporal lobe dysfunction in autism
and other related disorders: ADHD and OCD’, Latin American Journal
of Nuclear Medicine, July 1999, available online: http://www.alabimnjournal.cl |
|
Golse
B, Debray-Ritzen P, Durosay P, Puget K, Michelson AM, ‘Alterations in
two enzymes: superoxide dismutase and glutathion peroxidase in
developmental infantile psychosis’, Revue Neurologic (Paris)
1978 Nov;134(11):699-705 |
|
Gosselin
RE, Smith RP, Hodge HC, Clinical Toxicology of Commercial Products,
Section III, Therapeutic Index, 'Mercury',
(5th edition), Baltimore,
Williams & Wilkins, 1984: pp262-271. |
|
Grandin
T, ‘Brief Report: Response to National Institutes of Health Report’,
Journal of Autism and Developmental Disorders, 1996, Vol. 26, No.
2, 185-187 |
|
Grandin
T, ‘The Learning Style of People With Autism: An Autobiography’, Teaching
Children with Autism, Kathleen Ann Quill, 33-52 |
|
Grandjean
P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P, Debes F, Keiding
N, ‘Methylmercury exposure biomarkers as indicators of neurotoxicity
in children aged 7 years’, Am J Epidemiol 1999 Aug 1;
150(3):301-305 |
|
Grandjean
P, Guldager B, Larsen IB, Jergensen PJ, Holmstrup P, ‘Placebo Response
in Environmental Disease’, JOEM 1997 August, Vol. 38, No.
8,707-714 |
|
Grandjean
P, Weihe P, White RF, Debes F, ‘Cognitive performance of children
prenatally exposed to “safe” levels of methylmercury’, Environmental
Research 1998 May; 77(2): 165-172 |
|
Grandjean
P, White RF, Nielsen A, Cleary D, de Oliveira Santos EC,
‘Methylmercury neurotoxicity in Amazonian children downstream from
gold mining’, Environ Health Perspect 1999 Jul;107(7):587-591 |
|
Grundt
IK, Stensland E, Syverson TL, ‘Changes in fatty acid composition of
myelin cerebrosides after treatment of the developing rat with
methylmercury chloride and diethylmercury’. J Lipid Res, 1980
Feb;21(2):162-168 |
|
Gunderson,
VM, Grant KS, Burbacher TM, Fagan 3rd
JF, Mottet, NK, ‘The effect of low-level prenatal methyl mercury
exposure on visual recognition memory in infant crab-eating macaques’,
Child Dev., 1986, 57(4):1076-1083 |
|
Gunderson,
VM, Grant KS, Burbacher TM, et al, ‘Visual recognition memory deficits
in methyl mercury exposed Macaca fascicularis infants’, Neurotoxicol
Teratol., 1988, 10(4):373-379 |
|
Gupta
S, Aggarwal S, Heads C, ‘Brief Report: Dysregulated Immune System in
Children with Autism: Beneficial Effects of Intravenous Immun Globulin
on Autistic Characteristics’, Journal of Autism and Developmental
Disorders, 1996, Vol. 26, No. 4, 439-452 |
|
Gupta
S, Aggarwal S, Rashanravan B, Lee T, ‘Th1- and Th2-like cytokines in
CD4+ and CD8+ T cells in autism’, J Neuroimmunol 1998 May
1;85(1):106-109 |
|
Haeney
MR, Carter GF, Yeoman WB, Thompson RA, ‘Long-term parental exposure to
mercury in patients with hypogammaglobulinaemia’, British Medical
Journal 1979 2:12-14 |
|
Hagerman
RJ, 'Possible similarities between the fragile X and Asperger syndrome',
American Journal of Diseases of Children, 1987;141:601-602 |
|
Halsey
NA, 'Perspective on the use of thimerosal-containing vaccines',
presentation at the National Vaccine Advisory Committee Workshop on
Thimerosal and Vaccines, August 11-12, 1999, available on
Institute of Vaccine Safety website, www.vaccinesafety.edu |
|
Halsey
NA, ‘Limiting Infant Exposure to Thimerosal in Vaccines and Other
Sources of Mercury’, JAMA, November 10, 1999, Vol. 282, No. 18 |
|
Hartman
DE, 'Missed diagnoses and misdiagnoses of environmental toxicant
exposure', Diagnostic Dilemmas, Part I, 1998 Sep;21(3):659-671 |
|
Hashimoto
T, Tayama M, Miyazaki M, Sakurama N, Yoshimoto T, Murakawa K, Kuroda Y,
‘Reduced brainstem size in children with autism’, Brain &
Development, 1992, Vol. 14, No. 2, pp. 94-97 |
|
Hashimoto
T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y,
‘Development of the brainstem and cerebellum in autistic patients’, Journal
of Autism and Developmental Disorders, 1995, Vol. 25, No. 1, pp.
1-18 |
|
Haznedar
MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E,
‘Anterior Cingulate Gyrus Volume and Glucose Metabolism in Autistic
Disorder’, Amercian Journal of Psychiatry 1997 Aug
154(8):1047-1050 |
|
Hepatitis
Control Report, ‘Uproar over a little-known preservative, thimerosal,
jostles U.S. hepatitis B vaccination policy’, Summer 1999, Vol. 4, No.
2 |
|
Hollander
E, Kaplan A, Cartwright C, Reichman D, ‘Venlafaxine in children,
adolescents, and young adults with autism spectrum disorders: an open
retrospective clinical report’, J Child Neurol, 2000, Feb;15(2):132-135 |
|
Hoon
AH and Riess AL, ‘The mesial-temporal lobe and autism: case report and
review’, Developmental Medicine and Child Neurology 1992
34:252-265 |
|
Horvath
K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT,
‘Gastrointestinal abnormalities in children with autistic disorder’,
Journal of Pediatrics 1999 Nov 135(5):559-563 |
|
Hoshino
Y, Watanabe M, Kumashiro H, ‘The hypothalamo-pituitary function in
autistic children: the change of serum 5HT, plasma human growth hormone,
prolactin level after L-5HTP loading’, Neurosciences, 1984,
Vol. 10, pp. 285-291 |
|
Hoshino
Y, Watanabe M, Kumashiro H, ‘The TRH and LH-RH loading test in
autistic children’, Journal of Medical Science, 1985, Vol. 31,
No. 1 |
|
Howlin
P, 'Outcome in adult life for more able individuals with autism or
Asperger syndrome', Autism 2000 Mar;4(1):63-84 |
|
Hrdina
PD, Peters DA, Singhal RL 1976, ‘Effects of chronic exposure to
cadmium, lead and mercury of brain biogenic amines in the rat’, Research
Communications in Chemistry, Pathology and Pharacology 1976 Nov;15(3):483-493 |
|
Hu
H, Abedi-Valugerdi M, Moller G, ‘Pretreatmet of lymphocytes with
mercury in vitro induces a response in T cells from genetically
determine low-responders and a shift of the interleukin profile’, Immunology,
1997 90:198-204 |
|
Hu
H, Möller G, Abedi-Valugerdi M, ‘Major histocompatibility complex
class II antigens are required for both cytokine production and
proliferation induced by mercuric chloride in vitro’, J Autoimmun,
Oct 1997, 10(5):441-446 |
|
Hu
H, Moller G, Abedi-Valugerdi M, ‘Mechanism of mercury-induced
autoimmunity: both T helper 1- and T helper 2-type responses are
involved’, Immunology, March 1999, 96(3):348-357 |
|
Hua
MS, Huang CC, Yang YJ, 'Chronic elemental mercury intoxication:
neuropsychological follow up case study', Brain Inj 1996 May;10(5):377-84 |
|
Hultman
P, Hansson-Georgiadis H, ‘Methyl mercury-induced autoimmunity in
mice’, Toxicol Appl Pharmacol, Feb 1, 1999, 154(3):203-211 |
|
Hultman
| |
